EcoDrugPlus

Ensembl ID : YOR259C
Description: -
85 Possible Orthologues:

Title

Ensembl ID : YOR261C
Description: -
74 Possible Orthologues:

Title

Ensembl ID : YOR291W
Description: -
352 Possible Orthologues:

Title

Ensembl ID : YOR312C
Description: -
136 Possible Orthologues:

Title

Ensembl ID : YOR362C
Description: -
75 Possible Orthologues:

Title

Ensembl ID : YOR369C
Description: -
87 Possible Orthologues:

Title

Ensembl ID : YOR384W
Description: -
369 Possible Orthologues:

Title

Ensembl ID : YPL036W
Description: -
1082 Possible Orthologues:

Title

Ensembl ID : YPL079W
Description: -
107 Possible Orthologues:

Title

Ensembl ID : YPL081W
Description: -
89 Possible Orthologues:

Title

Ensembl ID : YPL090C
Description: -
114 Possible Orthologues:

Title

Ensembl ID : YPL116W
Description: -
208 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).